Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-β deposition in vivo

Microscopy Research and Technique

Volumn 50, Issue 4, 2000, Pages 297-304

  Fagan, Anne M ^a   Holtzman, David M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; A ; Cerebrospinal fluid; Lipid metabolism

Indexed keywords

BRAIN; CEREBROSPINAL FLUID; GLYCOPROTEINS; MAMMALS; METABOLISM; NEURODEGENERATIVE DISEASES; NEURONS; PARTICLE SIZE ANALYSIS;

ALZHEIMERS DISEASE; AMYLOID-Β; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; IN-VIVO; ISOFORMS; LIPID METABOLISMS; LIPOPROTEIN METABOLISM; NEURONAL FUNCTION; TRANSGENIC MICE;

LIPOPROTEINS;

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CYTOSKELETON PROTEIN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN;

ALZHEIMER DISEASE; ASTROCYTE; CEREBROSPINAL FLUID; GENOTYPE; LIPID PEROXIDATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE FIBER GROWTH; NERVE FUNCTION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENILE PLAQUE; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0034663336     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0029(20000815)50:4<297::AID-JEMT9>3.0.CO;2-C     Document Type: Review

References (125)

1. Albers JJ, Tollerfson JH, Wofbauer G, Albright RE. 1992. Cholesteryl ester transfer protein in human brain. Int J Clin Lab Res 21:264-266.
2. Anderson R, Higgins GA. 1997. Absence of central cholinergic deficits in apoE knockout mice. Psychopharmacology 132:135-144.
3. Arendt T, Schindler C, Bruckner MK, Eschrich K, Bigl V, Zedlick D, Marcova L. 1997. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ∈4 allele. J Neurosci 17:516-529.
4. Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B, Paul SM. 1997. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nature Genet 17:263-264.
5. V717F transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 96:15233-15238.
6. Beffert U, Danik M, Krzywkowski P, Ramassamy C, Berrada F, Poirier J. 1998. The neurobiology of apoproteins and their receptors in the CNS and Alzheimer's disease. Brain Res Rev 27:119-142.
7. Behl C, Davis J, Lesley R, Schubert D. 1994a. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827.
8. Behl C, Davis JB, Klier FG, Schubert D. 1994b. Amyloid beta peptide induces necrosis rather than apoptosis. Brain Res 645:253-264.
9. Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE. 1995. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem 270:27063-27071.
10. Biere AL, Ostaszewski B, Stimson ER, Hyman BT, Maggio JE, Selkoe DJ. 1996. Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma. J Biol Chem 271:32916-32922.
11. Borghini I, Barja F, Pometta D, James RW. 1995. Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochem Biophys Acta 1255:192-200.
12. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. 1985. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76:1501-1513.
13. Bu G, Maksymovitch EA, Nerbonne JM, Schwartz AL. 1994. Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J Biol Chem 269: 18521-18528.
14. Butterfield DA, Hensley K, Harris M, Mattson M, Carney J. 1994. β-amyloid peptide free radical fragments initiate synaptosomal lipoperixidation in a sequence-specific fashion: Implications to Alzheimer's disease. Biochem Biophys Res Commun 200:710-715.
15. Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke L, Mahley RW. 1999. Expression of human apolipoprotein E3 or E4 in the brains of apoE -/- mice: Isoform-specific effects on neurodegeneration. J Neurosci 19:4867-4880.
16. Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C, Frangione B. 1995. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. Biochem J 306:599-604.
17. Castro GR, Fielding CJ. 1984. Evidence for the distribution of apolipoprotein E between lipoprotein classes in human normocholesterolemic plasma and for the origin of unassociated apolipoprotein E (Lp-E). J Lipid Res 25:58-67.
18. Choi-Miura NH, Ihara Y, Fukuchi K, Takeda M, Nakano Y, Tobe T, Tomita M. 1992. SP-40,40 is a constituent of Alzheimer's amyloid. Acta Neuropath 83:260-264.
19. Christie RH, Chung H, Rebeck GW, Strickland D, Hyman BT. 1996. Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease. J Neuropath Exp Neurol 55:491-498.
20. Crutcher KA, Clay MA, Scott SA, Tian X, Tolar M, Harmony JAK 1994. Neurite degeneration elicited by apolipoprotein E peptides. Exp Neurol 130:120-126.
21. DeMattos RB, Curtiss LK, Williams DL. 1998. A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins. J Biol Chem 273:4206-4212.
22. DeMattos RB, Thorngate FE, Williams DL. 1999. A test of the cytosolic apolipoprotein E hypothesis fails to detect the excape of apolipoprotein E from the endocytic pathway into the cytosol and shows that direct expression of apolipoprotein E in the cytosol is cytotoxic. J Neurosci 19:2464-2473.
23. Diedrich JF, Minnigan H, Carp RI, Whitaker JN, Race R, Frey W, Haase AT. 1991. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 65:4759-4768.
24. Dong LM, Weisgraber KH. 1996. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem 271: 19053-19057.
25. Dong LM, Wilson C, Wardell MR, Simmons T, Mahley RW, Weisgraber KH, Agund DA. 1994. Human apolipoprotein E: Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem 269:22358-22365.
26. Elshourbagy NA, Liao WS, Mahley RW, Taylor JM. 1985. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci USA 82:203-207.
27. Evans KC, Berger EP, Cho C-G, Weisgraber KH, Lansbury PT. 1994. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer's disease. Proc Natl Acad Sci USA 92:763-767.
28. Fagan AM, Bu G, Sun Y, Daugherty A, Holtzman DM. 1996. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J Biol Chem 271:30121-30125.
29. Fagan AM, Murphy BA, Patel SN, Kilbridge JF, Mobley WC, Bu G, Holtzman DM. 1998. Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury. Exp Neurol 151:314-325.
30. Fagan AM, Holtzman DM, Munson G, Mathur T, Schneider D, Chang LK, Getz GS, Reardon CA, Lukens J, Shah JA, LaDu MJ. 1999. Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice. J Biol Chem 274: 30001-30007.
31. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527.
32. Genis I, Gordon I, Sehayek E, Michaelson DM. 1995. Phosphorylation of tau in apolipoprotein E-deficient mice. Neurosci Letts 199:5-8.
33. Ghiselli G, Schaefer EJ, Gascon P, Brewer HB Jr. 1981. Type III hyperlipoproteinemia associated with plasma apolipoprotein E deficiency. Science 214:1239-1241.
34. Ghiso J, Matsubara E, Koudinov A, Choi-Miura NH, Tomita M, Wisniewski T, Frangione B. 1993. The cerebrospinal-fluid form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem J 293:27-30.
35. Goodrum JF. 1991. Cholesterol from degenerating nerve myelin becomes associated with lipoproteins containing apolipoprotein E. J Neurochem 56:2082-2086.
36. Gregg R, Zech L, Schaefer E, Stark D, Wilson D, Brewer H.. 1986. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 78:815-821.
37. Handelmann GE, Boyles JK, Weisgraber KH, Mahley RW, Pitas RE. 1992. Effects of apolipoprotein E, β-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J Lipid Res 33:1677-1688.
38. Harr SD, Uint L, Hollister R, Hyman BT, Mendez AJ. 1996. Brain expression of apolipoproteins E, J and A-I in Alzheimer's disease. J Neurochem 66:2429-2435.
39. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA, Butterfield DA. 1994. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc Natl Acad Sci USA 91:3270-3274.
40. Holtzman DM, Pitas RE, Kilbridge J, Nathan B, Mahley RW, Bu G, Schwartz AL. 1995. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a CNS-derived neuronal cell line. Proc Natl Acad Sci USA 92:9480-9484.
41. Holtzman DM, Bales KR, Wu S, Bhat P, Parsadanian M, Fagan AM, Chang LK, Sun Y, Paul SM. 1999. Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease. J Clin Invest 103:R15-R21.
42. Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B, Olney J, McKeel D, Wozniak D, Paul SM. 2000. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA, in press.
43. Horsburgh K, Kelly S, McCulloch J, Higgins GA, Roses AD, Nicoll JAR. 1999. Increased neuronal damage in apolipoprotein E-deficient mice following global ischemia. NeuroReport 10:837-841.
44. Hyman BT, West ML, Rebeck GW, Buldyrev SV, Mantegna RN, Ukleja M, Havlin S, Stanley HE. 1995. Quantitative analysis of senile plaques in Alzheimer disease: Observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21. Proc Natl Acad Sci USA 92:3586-3590.
45. Ignatius MJ, Gebicke-Harter PJ, Skene JHP, Schilling JW, Weisgraber KH, Mahley RW, Shooter EM. 1986. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA 83:1125-1129.
46. Ignatius MJ, Shooter EM, Pitas RE, Mahley RW. 1987. Lipoprotein uptake by neuronal growth cones in vitro. Science 236:959-962.
47. Jordán J, Galindo MF, Miller RJ, Reardon CA, Getz GS, LaDu MJ. 1998. Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J Neurosci 18:195-204.
48. Keller JN, Pang Z, Geddes JW, Beggley JG, Germeyer A, Waeg G, Mattson MP. 1997. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: Role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 69:273-284.
49. Kim DH, Iijima H, Goto K, Sakai J, Ishii H, Kim HJ, Suzuki H, Kondo H, Saeki S, Yamamoto T. 1996. Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoportein receptor family predominantly expressed in brain. J Biol Chem 271:8373-8380.
50. Koudinov A, Matsubara E, Frangione B, Ghiso J. 1994. The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma. Biochem Biophys Res Comm 205:1164-1171.
51. Koudinov AR, Koudinova NV, Kumar A, Beavis RC, Ghiso J. 1996. Biochemical characterization of Alzheimer's soluble beta protein in human cerebrospinal fluid - association with high density lipoprotein. Biochem Biophys Res Commun 223:592-597.
52. Kowalewski T, Holtzman DM. 1999. In situ AFM study of Alzheimer's β-amyloid peptide on different substrates: New insights into mechanism of βsheet formation. Proc Natl Acad Sci USA 96:3688-3693.
53. Krause D, Debuch H. 1987. Lipid changes of astrocytes from mouse cerebellum cultured in lipid-free chemically defined medium and in serum-supplemented medium. Neurosci Letts 82:53-57.
54. Krieger M, Herz J. 1994. Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 63:601-637.
55. Krul ES, Tang J. 1992. Secretion of apolipoprotein E by an astrocytoma cell line. J Neurosci Res 32:227-238.
56. Kuipers F, Van Ree JM, Hofker MH, Wolters H, Veld GI, Havinga R, Vonk RJ, Princen HMG, Havekes LM. 1996. Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver. Hepatology 24:241-247.
57. LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE. 1994. Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 269:23404-23406.
58. LaDu MJ, Pederson TM, Frail DE, Reardon CA, Getz GS, Falduto MT. 1995. Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J Biol Chem 270:9030-9042.
59. LaDu MJ, Gilligan SM, Lukens SR, Cabana VG, Reardon CA, Van Eldik LJ, Holtzman DM. 1998. Nascent astroctye particles differ from lipoproteins in CSF. J Neurochem 70:2070-2081.
60. Laskowitz DT, Sheng H, Bart RD, Joyner KA, Roses AD, Warner DS. 1997. Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia. J Cereb Blood Flow Metab 17:753-8.
61. Linton MF, Gish R, Hubl ST, Butler E, Esquivel C, Bry WI, Boyles JK, Wardell MR, Young SG. 1991. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest 88:270-281.
62. Lorent K, Overbergh L, Moechars D, destrooper B, Vanleuven H, Vandenburghe H. 1995. Expression in mouse embryos and in adult mouse brain of three members of the amyloid precursor protein family, of the alpha-2-macroglobulin receptor/low density lipoprotein receptor-related protein and of its ligands apolipoprotein E, lipoprotein lipase, alpha-2-macroglobulin and the 40,000 molecular weight receptor-associated protein. Neurosci 65:1009-1025.
63. Ma J, Yee A, Brewer HB, Das S, Potter H. 1994. Amyloid-associated proteins alpha-1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372:92-94.
64. Ma J, Brewer H, Potter H. 1996. Alzheimer Aβ neurotoxicity: Promotion by anti-chymotrypsin, apoE4; inhibition by Aβ-related peptides. Neurobiol Aging 17:773-780.
65. Mahley RW. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240:622-630.
66. Mark RJ, Lovell MA, Marksbery WR, Uchida K, Mattson MP. 1997. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J Neurochem 68:255-264.
67. Markesbery WR. 1999. The role of oxidative stress in Alzheimer's disease. Arch Neurol 56:1449-1452.
68. Marques MA, Tolar M, Harmony JAK, Crutcher KA. 1996. A thrombin cleavage product of apolipoprotein E exhibits isoform-specific neurotoxocity. NeuroReport 7:2529-2532.
69. Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD. 1995. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol 136:107-122.
70. Masliah E, Samuel W, Veinbergs I, Mallory M, Mante M, Saitoh T. 1997. Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Res 751:307-314.
71. Mattson MP. 1998. Modification of ion homeostasis by lipid peroxidation: Roles in neuronal degeneration and adaptive plasticity. Trends Neurosci 21:53-57.
72. Metzger RE, LaDu MJ, Pan JB, Getz GS, Frail DE, Falduto MT. 1996. Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: Implications for Alzheimer's disease. J Exp Neuropathol Exp Neurol 55:372-380.
73. Michikawa M, Yanagisawa K. 1998. Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis. J Neurosci Res 54:58-67.
74. Miyata M, Smith JD. 1996. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nature Genet 14:55-61.
75. Moestrup SK, Gliemann J, Pallesen G. 1992. Distribution of the α2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tiss Res 269:375-382.
76. Montine KS, Olson SJ, Amarnath V, Whetsell WO, Jr., Graham DG, Montine TJ. 1997a. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am J Pathol 150:437-443.
77. Montine TJ, Montine KS, Swift LL. 1997b. Central nervous system lipoproteins in Alzheimer's disease. Am J Pathol 151:1571-1575.
78. Montine TJ, Montine KS, Olson SJ, Graham DG, Roberts LJ, Morrow JD, Linton MF, Fazio S, Swift LL. 1999. Increased cerebral cortical lipid peroxidation and abnormal phospholipids in aged homozygous apoE-deficiency C57BL/6J mice. Exp Neurol 158:234-241.
79. Mouchel Y, Lefrancois T, Fages C, Tardy M. 1995. Apolipoprotein E expression in astrocytes: developmental pattern and regulation. Neuroreport 7:205-208.
80. Moulder KL, Narita M, Chang LK, Bu GJ, Johnson EM. 1999. Analysis of a novel mechanism of neuronal toxicity produced by an apolipoprotein E-derived peptide. J Neurochem 72:1069-1080.
81. Nakai M, Kawamata T, Maeda K, Tanaka C. 1996. Expression of apoE mRNA in rat microglia. Neurosci Lett 211:41-44.
82. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. 1991. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541:163-166.
83. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE. 1994. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264:850-852.
84. Nathan BP, Chang KC, Bellosta S, Brisch E, Ge N, Mahley RW, Pitas RE. 1995. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem 270:19791-19799.
85. Novak S, Hiesberger T, Schneider WJ, Nimpf J. 1996. A new low density lipoprotein receptor homologue with 8 ligand binding repeats. J Biol Chem 271:11732-11736.
86. Pillot T, Goethals M, Vanloo B, Lins L, Brasseur R, Vandekerckhove J, Rosseneu M. 1997. Specific modulation of the fusogenic properties of the Alzheimer β-amyloid peptide by apolipoprotein E isoforms. Eur J Biochem 243:650-659.
87. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW. 1987a. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 917:148-161.
88. Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH. 1987b. Lipoproteins and their receptors in the central nervous system. J Biol Chem 262:14352-14360.
89. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71:343-353.
90. Poirer J. 1994. Apolipoprotein E in animal models of CNS injury and Alzheimer's disease. Trends Neurol Sci 17:525-530.
91. Poirier J, Hess M, May PC, Finch CE. 1991. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol Brain Res 11:97-106.
92. Poirier J, Baccichet A, Dea D, Gauthier S. 1993. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neurosci 55:81-90.
93. Popko B, Goodrum JF, Bouldin TW, Zhang SH, Maeda N. 1993. Nerve regeneration occurs in the absence of apolipoprotein E in mice. J Neurochem 60:1155-1158.
94. 2-isoprostanes, in vivo markers of lipid peroxidation. J Neurochem 73:736-741.
95. Ramassamy C, Averill D, Beffert U, Bastianetto S, Theroux L, Lussier-Cacan S, Cohn JS, Christen Y, Davignon J, Quirion R, Poirier J. 1999. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radical Biol Med 27:544-553.
96. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. 1993. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11:575-580.
97. Robertson FW, Cumming AM. 1985. Effects of apolipoprotein E polymorphism on serum lipoprotein concentration. Arteriosclerosis 5:283-292.
98. Roheim PS, Carey M, Forte T, Vega GL. 1979. Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci USA 76:4646-4649.
99. Roses AD. 1997. Apolipoprotein E, a gene with complex biological interactions in the aging brain. Neurobiol Dis 4:170-186.
100. Sanan DA, Weisgraber KH, Russel SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewksi T, Frangione B, Roses B, Roses AD, Strittmatter WJ. 1994. Apolipoprotein E associates with β-amyloid peptide of Alzheimer's disease to form novel monofibrils. J Clin Invest 94:860-869.
101. Schaefer EJ, Gregg RE, Gheselli G, Forte TM, Ordovas JM, Zech LA, Brewer HB, Jr. 1986. Familial apolipoprotein E deficiency. J Clin Invest 78:1206-1219.
102. Schmechel DE, Saunders AM, Strittmattter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD. 1993. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:9649-9653.
103. Sheng HX, Laskowitz DT, Mackensen GB, Kudo M, Pearlstein RD, Warner DS. 1999. Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse. Stroke 30:1118-1123.
104. Sing CF, Davignon J. 1985. Role of apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37:268-285.
105. Smith KM, Lawn RM, Wilcox JN. 1990. Cellular localization of apolipoprotein D and lecithin:cholesterol transferase mRNA in rhesus monkey tissues by in-situ hybridization. J Lipid Res 31:995-1004.
106. Steinmetz A, Jakobs C, Motzny S, Kaffarnik H. 1989. Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins. Arteriosclerosis 9:405-411.
107. Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Hajian H, Finch CE. 1997. Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp Neurol 143:313-318.
108. Strittmatter WJ, Roses AD. 1996. Apolipoprotein E and Alzheimer's disease. Annu Rev Neurosci 19:53-77.
109. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. 1993a. Apolipoprotein E: High avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977-1981.
110. Strittmatter WJ, Weisgraber KH, Huang DY, Dong L-Y, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD. 1993b. Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform specific-effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:8098-8102.
111. Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong L-M, Jakes R, Huang DY, Pericak-Vance M, Schmechel D, Roses AD. 1994. Isoform-specific interactions of apolipoprotein E with microtubule-associated tau: Implications for Alzheimer disease. Proc Natl Acad Sci USA 91:11183-11186.
112. Sun Y, Wu S, Bu G, Onifade MK, Patel SN, LaDu MJ, Fagan AM, Holtzman DM. 1998. GFAP-apoE transgenic mice: Astrocyte specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J Neurosci 18:3261-3272.
113. Teter B, Xu P-T, Gilbert JR, Roses AD, Galasko D, Cole GM. 1999. Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture. J Neurochem 76: 2613-2615.
114. Tolar M, Marques MA, Harmony JAK, Crutcher KA. 1997. Neurotoxicity of the 22kDa thrombin cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated. J Neurosci 17:5678-5686.
115. Utermann G, Hees M, Steinmetz A. 1977. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man. Nature 269:604-607.
116. Utermann G, Pruin N, Steinmetz A. 1979. Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet 15:65-72.
117. Warden CH, Langner CA, Gordon JI, Taylor BA, McLean JW, Lusis AJ. 1989. Tissue-specific expression, developmental regulation and chromosomal mapping of the lecithin: cholesterol acytransferase gene. J Biol Chem 264:21573-21581.
118. Weisgraber KH. 1990. Apolipoprotein E distribution among plasma lipoproteins: role of the cystine-arginine interchange at residue 112. J Lipid Res 31:1503-1511.
119. Weisgraber KH. 1994. Apolipoprotein E: structure-function relationships. Adv Protein Chem 45:249-302.
120. Wisniewski T, Ghiso J, Frangione B. 1997. Biology of Aβ amyloid in Alzheimer's disease. Neurobiol Dis 4:313-328.
121. Wolf BB, Loppes MBS, VandenBerg SR, Gonias S. 1992. Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low density lipoprotein receptor-related protein) in human brain. Am J Pathol 141:37-42.
122. s) is preferentially associated with neuron-enriched cultures from APOE transgenic mice. Neurobiol Dis 6:63-75.
123. Yang D-S, Smith JD, Zhou Z, Gandy S, Martins RN. 1997. Characterization of the binding of amyloid-β peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma. J Neurochem 68:721-725.
124. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258:468-471.
125. Zhou Z, Smith JD, Greengard P, Gandy S. 1996. Alzheimer amyloid-β peptide forms denaturant-resistant complex with type ∈3 but not type ∈4 isoform of native apolipoprotein E. Mol Med 2:175-180.